For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable ...

Scientists have taken a small but significant step toward testing the idea of reverse aging in humans. Researchers have ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.

Human-induced pluripotent stem cells (hiPSCs) can differentiate into various tissues, an invaluable characteristic for personalized regenerative medicine, basic and translational research, and drug ...

Over the past several months, advancements in artificial intelligence (AI) have led some high-profile companies to attempt to ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...